Related Experiment Video
Updated: Aug 12, 2025

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
Published on: December 8, 2023
[PEDIATRIC ONCOLOGY, HEMATOLOGY AND BONE MARROW TRANSPLANTATION - PAST PRESENT AND FUTURE FOR PATIENTS]
1Israeli Society of Pediatric Hematology and Oncology, The Joan and Sanford Weill Pediatric Hematology Oncology and Bone Marrow Transplantation Division, Ruth Rappaport Children's Hospital, Rambam Health Care Campus, Haifa, Israel.
Insights
Pediatric cancer and blood disorder treatments have advanced significantly due to better understanding and innovative therapies. Focus now shifts to managing recurrence and long-term side effects for improved survivor quality of life.
Area of Science:
- Pediatric Hematology-Oncology
- Cancer Genomics
- Immunotherapy
Background:
- Integrated care for pediatric hematological and oncological diseases in Israel.
- Recent decades show dramatic treatment improvements driven by biological insights, novel medications, and technology.
Approach:
- Review of advancements in common pediatric hematology and oncology diseases.
- Emphasis on molecular diagnostics for accurate disease identification.
- Integration of precision medicine with innovative biological and immunotherapeutic drugs.
Key Points:
- Utilizing molecular tests for precise diagnosis in pediatric cancers.
- Implementing precision medicine for targeted treatment strategies.
- Investigating congenital genetic diseases linked to cancer development.
- Highlighting ongoing research and departmental work in pediatric oncology.
Conclusions:
- Continued advancements in pediatric oncology and hematology.
- Ongoing challenges include managing disease recurrence and treatment side effects.
- Improving long-term quality of life for childhood cancer survivors is a key goal.
Introduction:
The treatment of children with oncological and hematological diseases and bone marrow transplantations is under the same roof in the departments and units in Israel. The dramatic improvement in recent decades is a result of the biological understanding of the diseases, new biological and immunological medications, technological progress, database registration, joining large international groups and clinical trials in medical treatment as well as improvements in radiation therapy, surgery and supportive care. In this booklet, we present review articles on the progress in some of the common diseases in hematology and oncology for children, emphasizing the molecular tests that can be used to determine the diagnosis, introducing precision medicine implementing innovative biological and immunotherapeutic drugs and in order to shed light on the diagnosis of congenital genetic disease exposing cancer development. We also update on the work being conducted in the various departments in these fields. As more than 84% of all children diagnosed with cancer will experience long-term survival or cure, the significant challenges remaining for the treatment teams today include treating the recurrence of disease, as well as reducing the long-term side effects in order to improve the quality of life of the survivors.
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Multipotency of Hematopoietic Stem Cells
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

